{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:06:07Z","timestamp":1769087167644,"version":"3.49.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T00:00:00Z","timestamp":1716940800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>T cell dysfunction, which includes exhaustion, anergy, and senescence, is a distinct T cell differentiation state that occurs after antigen exposure. Although T cell dysfunction has been a cornerstone of cancer immunotherapy, its potential in transplant research, while not yet as extensively explored, is attracting growing interest. Interferon regulatory factor 4 (IRF4) has been shown to play a pivotal role in inducing T cell dysfunction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>A novel ultra-low-dose combination of Trametinib and Rapamycin, targeting IRF4 inhibition, was employed to investigate T cell proliferation, apoptosis, cytokine secretion, expression of T-cell dysfunction-associated molecules, effects of mitogen-activated protein kinase (MAPK) and mammalian target of rapamycin (mTOR) signaling pathways, and allograft survival in both <jats:italic toggle=\"yes\">in vitro<\/jats:italic> and BALB\/c to C57BL\/6 mouse cardiac transplantation models.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>\n                                 <jats:italic toggle=\"yes\">In vitro<\/jats:italic>, blockade of IRF4 in T cells effectively inhibited T cell proliferation, increased apoptosis, and significantly upregulated the expression of programmed cell death protein 1 (PD-1), Helios, CD160, and cytotoxic T lymphocyte-associated antigen (CTLA-4), markers of T cell dysfunction. Furthermore, it suppressed the secretion of pro-inflammatory cytokines interferon (IFN)-\u03b3 and interleukin (IL)-17. Combining ultra-low-dose Trametinib (0.1 mg\u00b7kg<jats:sup>\u22121<\/jats:sup>\u00b7day<jats:sup>\u22121<\/jats:sup>) and Rapamycin (0.1 mg\u00b7kg<jats:sup>\u22121<\/jats:sup>\u00b7day<jats:sup>\u22121<\/jats:sup>) demonstrably extended graft survival, with 4 out of 5 mice exceeding 100 days post-transplantation. Moreover, analysis of grafts at day 7 confirmed sustained IFN regulatory factor 4 (IRF4) inhibition, enhanced PD-1 expression, and suppressed IFN-\u03b3 secretion, reinforcing the <jats:italic toggle=\"yes\">in vivo<\/jats:italic> efficacy of this IRF4-targeting approach. The combination of Trametinib and Rapamycin synergistically inhibited the MAPK and mTOR signaling network, leading to a more pronounced suppression of IRF4 expression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Targeting IRF4, a key regulator of T cell dysfunction, presents a promising avenue for inducing transplant immune tolerance. In this study, we demonstrate that a novel ultra-low-dose combination of Trametinib and Rapamycin synergistically suppresses the MAPK and mTOR signaling network, leading to profound IRF4 inhibition, promoting allograft acceptance, and offering a potential new therapeutic strategy for improved transplant outcomes. However, further research is necessary to elucidate the underlying pharmacological mechanisms and facilitate translation to clinical practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/cm9.0000000000003198","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T03:00:09Z","timestamp":1717038009000},"page":"1202-1212","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Inhibition of interferon regulatory factor 4 orchestrates T cell dysfunction, extending mouse cardiac allograft survival"],"prefix":"10.1097","volume":"138","author":[{"given":"Wenjia","family":"Yuan","sequence":"first","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hedong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longkai","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"},{"name":"Medical College, Guangxi University, Nanning, Guangxi 530004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouqi","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengcheng","family":"Cui","sequence":"additional","affiliation":[{"name":"Medical College, Guangxi University, Nanning, Guangxi 530004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaguang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengfang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Qiu","sequence":"additional","affiliation":[{"name":"Medical College, Guangxi University, Nanning, Guangxi 530004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Cui","sequence":"additional","affiliation":[{"name":"Medical College, Guangxi University, Nanning, Guangxi 530004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinqi","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiadi","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xubiao","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Organ Transplantation, The Fifth Clinical Medical College of Henan University of Chinese Medicine (Zhengzhou People\u2019s Hospital), Zhengzhou, Henan 450000, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helong","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of Kidney Transplantation, Center of Organ Transplantation, The Second Xiangya Hospital of Central South University, Changsha, Hunan 410011, China"},{"name":"Medical College, Guangxi University, Nanning, Guangxi 530004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,5,29]]},"reference":[{"key":"R1-20250520","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41581-022-00600-0","article-title":"Activation and regulation of alloreactive T cell immunity in solid organ transplantation","volume":"18","author":"Duneton","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"R2-20250520","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1084\/jem.184.5.2013","article-title":"CD4+ but not CD8+ cells are essential for allorejection","volume":"184","author":"Krieger","year":"1996","journal-title":"J Exp Med"},{"key":"R3-20250520","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"R4-20250520","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.it.2013.10.001","article-title":"Tolerance and exhaustion: Defining mechanisms of T cell dysfunction","volume":"35","author":"Schietinger","year":"2014","journal-title":"Trends Immunol"},{"key":"R5-20250520","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fcell.2020.00017","article-title":"T cell dysfunction and exhaustion in cancer","volume":"8","author":"Zhang","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R6-20250520","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"key":"R7-20250520","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.kint.2019.01.040","article-title":"T-cell exhaustion correlates with improved outcomes in kidney transplant recipients","volume":"96","author":"Fribourg","year":"2019","journal-title":"Kidney Int"},{"key":"R8-20250520","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/eji.201344279","article-title":"IRF4 at the crossroads of effector T-cell fate decision","volume":"44","author":"Huber","year":"2014","journal-title":"Eur J Immunol"},{"key":"R9-20250520","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/ajt.15196","article-title":"Ablation of interferon regulatory factor 4 in T cells induces \u201cmemory\u201d of transplant tolerance that is irreversible by immune checkpoint blockade","volume":"19","author":"Zhang","year":"2019","journal-title":"Am J Transplant"},{"key":"R10-20250520","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.immuni.2017.11.003","article-title":"Ablation of transcription factor IRF4 promotes transplant acceptance by driving allogenic CD4+ T cell dysfunction","volume":"47","author":"Wu","year":"2017","journal-title":"Immunity"},{"key":"R11-20250520","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/TP.0000000000002914","article-title":"Poor outcomes with the use of checkpoint inhibitors in kidney transplant recipients","volume":"104","author":"Venkatachalam","year":"2020","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"R12-20250520","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"Special issue: KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","author":"Eckardt","year":"2009","journal-title":"Am J Transplant"},{"key":"R13-20250520","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/CCO.0000000000000505","article-title":"Immune checkpoint blockade for organ transplant patients with advanced cancer: How far can we go?","volume":"31","author":"De Bruyn","year":"2019","journal-title":"Curr Opin Oncol"},{"key":"R14-20250520","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s40425-019-0585-1","article-title":"Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: An institutional experience and a systematic review of the literature","volume":"7","author":"Abdel-Wahab","year":"2019","journal-title":"J Immunother Cancer"},{"key":"R15-20250520","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.apjtm.2017.05.004","article-title":"Preoperative application of combination of portal venous injection of donor spleen cells and intraperitoneal injection of rapamycin prolongs the survival of cardiac allografts in mice","volume":"10","author":"Gong","year":"2017","journal-title":"Asian Pac J Trop Med"},{"key":"R16-20250520","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/TP.0b013e31829b07b5","article-title":"Galectin-9 in combination with rapamycin induces cardiac allograft tolerance in mice","volume":"96","author":"Cai","year":"2013","journal-title":"Transplantation"},{"key":"R17-20250520","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1111\/ajt.13276","article-title":"Rapamycin prolongs cardiac allograft survival in a mouse model by inducing myeloid-derived suppressor cells","volume":"15","author":"Nakamura","year":"2015","journal-title":"Am J Transplant"},{"key":"R18-20250520","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/00007890-200405150-00002","article-title":"Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice","volume":"77","author":"Koehl","year":"2004","journal-title":"Transplantation"},{"key":"R19-20250520","doi-asserted-by":"crossref","first-page":"30670","DOI":"10.1073\/pnas.1920240117","article-title":"Unbiased in vivo preclinical evaluation of anticancer drugs identifies effective therapy for the treatment of pancreatic adenocarcinoma","volume":"117","author":"Grbovic-Huezo","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R20-20250520","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41467-019-09898-0","article-title":"MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer","volume":"10","author":"Zhan","year":"2019","journal-title":"Nat Commun"},{"key":"R21-20250520","doi-asserted-by":"crossref","first-page":"e1515057","DOI":"10.1080\/2162402X.2018.1515057","article-title":"Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma","volume":"8","author":"Kang","year":"2019","journal-title":"Oncoimmunology"},{"key":"R22-20250520","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"R23-20250520","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/jcp.1041540103","article-title":"Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle","volume":"154","author":"Terada","year":"1993","journal-title":"J Cell Physiol"},{"key":"R24-20250520","doi-asserted-by":"crossref","first-page":"101907","DOI":"10.1016\/j.ctrv.2019.101907","article-title":"Trametinib in the treatment of multiple malignancies harboring MEK1 mutations","volume":"81","author":"Lian","year":"2019","journal-title":"Cancer Treat Rev"},{"key":"R25-20250520","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: Cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem Sci"},{"key":"R26-20250520","doi-asserted-by":"crossref","first-page":"610","DOI":"10.18632\/oncotarget.315","article-title":"Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cells","volume":"2","author":"Taylor","year":"2011","journal-title":"Oncotarget"},{"key":"R27-20250520","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/leu.2008.27","article-title":"Targeting survival cascades induced by activation of Ras\/Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways for effective leukemia therapy","volume":"22","author":"McCubrey","year":"2008","journal-title":"Leukemia"},{"key":"R28-20250520","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1038\/s41467-020-16123-w","article-title":"Sequential Ras\/MAPK and PI3K\/AKT\/mTOR pathways recruitment drives basal extrusion in the prostate-like gland of drosophila","volume":"11","author":"Rambur","year":"2020","journal-title":"Nat Commun"},{"key":"R29-20250520","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.immuni.2013.10.007","article-title":"Interferon regulatory factor 4 sustains CD8+ T cell expansion and effector differentiation","volume":"39","author":"Yao","year":"2013","journal-title":"Immunity"},{"key":"R30-20250520","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.stem.2020.12.017","article-title":"Selective antisense oligonucleotide inhibition of human IRF4 prevents malignant myeloma regeneration via cell cycle disruption","volume":"28","author":"Mondala","year":"2021","journal-title":"Cell Stem Cell"},{"key":"R31-20250520","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12977-020-00535-z","article-title":"Interferon regulatory factor 4 as a therapeutic target in adult T-cell leukemia lymphoma","volume":"17","author":"Rauch","year":"2020","journal-title":"Retrovirology"},{"key":"R32-20250520","doi-asserted-by":"crossref","first-page":"5545","DOI":"10.1182\/blood-2019-130910","article-title":"A high-throughput drug screen reveals a novel compound class that significantly depletes IRF4 expression in multiple myeloma","volume":"134","author":"Lightbody","year":"2019","journal-title":"Blood"},{"key":"R33-20250520","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/362758a0","article-title":"Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells","volume":"362","author":"Moskophidis","year":"1993","journal-title":"Nature"},{"key":"R34-20250520","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1097\/TP.0b013e31816dd64a","article-title":"Exhaustive differentiation of alloreactive CD8+ T cells: Critical for determination of graft acceptance or rejection","volume":"85","author":"Steger","year":"2008","journal-title":"Transplantation"},{"key":"R35-20250520","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/00007890-199612270-00005","article-title":"Tolerance to rat liver allografts: IV. Acceptance depends on the quantity of donor tissue and on donor leukocytes","volume":"62","author":"Sun","year":"1996","journal-title":"Transplantation"},{"key":"R36-20250520","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4049\/jimmunol.172.1.240","article-title":"Effects of T cell frequency and graft size on transplant outcome in mice","volume":"172","author":"He","year":"2004","journal-title":"J Immunol"},{"key":"R37-20250520","doi-asserted-by":"crossref","first-page":"725618","DOI":"10.3389\/fimmu.2021.725618","article-title":"Schr\u00f6dinger\u2019s T cells: Molecular insights into stemness and exhaustion","volume":"12","author":"Gonzalez","year":"2021","journal-title":"Front Immunol"},{"key":"R38-20250520","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1111\/ajt.15870","article-title":"T cell exhaustion is associated with antigen abundance and promotes transplant acceptance","volume":"20","author":"Zou","year":"2020","journal-title":"Am J Transplant"},{"key":"R39-20250520","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"R40-20250520","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.celrep.2019.06.018","article-title":"Nitric oxide modulates metabolic remodeling in inflammatory macrophages through TCA cycle regulation and itaconate accumulation","volume":"28","author":"Bailey","year":"2019","journal-title":"Cell Rep"},{"key":"R41-20250520","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1097\/QAD.0000000000001997","article-title":"mTOR signaling mediates effects of common gamma-chain cytokines on T cell proliferation and exhaustion","volume":"32","author":"Taylor","year":"2018","journal-title":"AIDS"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T12:56:36Z","timestamp":1747745796000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CM9.0000000000003198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,29]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/cm9.0000000000003198","relation":{},"ISSN":["0366-6999","2542-5641"],"issn-type":[{"value":"0366-6999","type":"print"},{"value":"2542-5641","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,29]]},"assertion":[{"value":"2024-02-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}